Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Sonidegib> ?p ?o. }
Showing items 1 to 38 of
38
with 100 items per page.
- Sonidegib abstract "Sonidegib (INN) or erismodegib (USAN), also known as LDE225, is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) being developed as an anticancer agent by Novartis. It has been investigated as a potential treatment for: Pancreatic cancer Breast cancer Basal cell carcinoma of the skin Small cell lung cancer Medulloblastoma Advanced solid tumours (including ovarian, breast, pancreatic, stomach, oesophageal cancers and glioblastoma multiforme) Acute leukaemia Chronic myeloid leukaemia Myelofibrosis and essential thrombocythaemiaIt has demonstrated significant efficacy against melanoma in vitro and in vivo. It also demonstrated efficacy in a mouse model of pancreatic cancer.".
- Sonidegib iupacName "N-[6-[(2S,6R)-2,6-Dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide".
- Sonidegib pubchem "135626837".
- Sonidegib thumbnail Sonidegib2DACS.svg?width=300.
- Sonidegib wikiPageID "41957427".
- Sonidegib wikiPageRevisionID "598507672".
- Sonidegib c "26".
- Sonidegib chemspiderid "135626837".
- Sonidegib drugName "Sonidegib".
- Sonidegib f "3".
- Sonidegib h "26".
- Sonidegib image "Sonidegib3Dan.gif".
- Sonidegib iupacName "N-[6-[-2,6-Dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-phenyl]benzamide".
- Sonidegib legalStatus "Investigational".
- Sonidegib molecularWeight "485.498".
- Sonidegib n "3".
- Sonidegib o "3".
- Sonidegib pubchem "135626837".
- Sonidegib routesOfAdministration "Oral".
- Sonidegib smiles "CC1CNC2=NC=CNCC3=CC=CCC4=CC=COCF".
- Sonidegib stdinchi "1".
- Sonidegib stdinchikey "VZZJRYRQSPEMTK-CALCHBBNSA-N".
- Sonidegib width "200".
- Sonidegib subject Category:Benzamides.
- Sonidegib subject Category:Experimental_cancer_drugs.
- Sonidegib subject Category:Morpholines.
- Sonidegib subject Category:Pyridines.
- Sonidegib type Drug.
- Sonidegib type FunctionalSubstance.
- Sonidegib comment "Sonidegib (INN) or erismodegib (USAN), also known as LDE225, is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) being developed as an anticancer agent by Novartis.".
- Sonidegib label "Sonidegib".
- Sonidegib sameAs m.0_s4_pg.
- Sonidegib sameAs Q17152625.
- Sonidegib sameAs Q17152625.
- Sonidegib wasDerivedFrom Sonidegib?oldid=598507672.
- Sonidegib depiction Sonidegib2DACS.svg.
- Sonidegib isPrimaryTopicOf Sonidegib.
- Sonidegib name "Sonidegib".